ust as microelectronics and the resulting information technology shaped the scientific landscape of the 20th century, the acquisition, manipulation and application of biomedical information is likely to dominate 21st century science. Technologies for biological research, high-throughput screening and medical diagnosis will increasingly converge, and optical imaging, measurement and therapeutic techniques will play critical roles. In particular, optical microscopy will continue to provide a powerful way of studying cell and tissue function. In vivo optical imaging will become increasingly important for the diagnosis and monitoring of disease. Optical imaging can potentially provide more information than many other biomedical imaging modalities because the strong interaction of optical radiation with biological tissue permits the acquisition of "functional" information.
Fluorescence imaging is particularly powerful because the use of fluorescent labels can yield a high specificity and because appropriate analysis of the fluorescence signal can provide information about the environment of the fluorophore molecules as well as their location. Although fluorescence imaging is a long-established technique, recent advances in both label and detection technology are radically enhancing its impact in biomedicine. For cell biology and proteomics, for example, the use of genetically expressed fluorescence labels, such as green fluorescent protein (GFP), allows biologists to observe the location of specific proteins in living cells. For medical imaging, fluorescence can provide greater specificity than absorption-or scattering-based techniques because it can derive functional contrast from intrinsic autofluorescence and/or from exogenous fluorescence labels. As our understanding of cell biology, immunology and proteomics grows, the techniques developed for these research agendas will increasingly be applied directly in clinical practice. In particular, we are now seeing rapid growth in techniques to realize in vivo microscopy and high-resolution endoscopy, optical imaging tools that will make use of fluorescence to provide functional contrast.
Fluorescence contrast in bioimaging
Fluorescence microscopy, in which the sample absorbs incident photons and emits light (fluorescence) at different (longer) wavelengths, is a well-established way of providing contrast that is not achievable with reflected light microscopy. Since the wavelength of the emitted fluorescence depends on the energy level structure of the fluorescent molecules (or "fluorophores"), it may be used to distinguish different molecular species in a sample. Thus, qualitative imaging of fluorescence intensity can reveal the location or distribution of fluorophores and spectrally resolved intensity imaging can contrast different fluorophores if their fluorescence emission spectra are sufficiently different.
In biological samples, almost all the constituents will exhibit fluorescence if excited at an appropriate wavelength. For example, ultraviolet radiation can excite many organic molecules. This is often a problem since the aim is usually to study one or two specific biological entities and normally the excitation wavelength is carefully chosen so that it only excites the molecular species of interest. Another consideration for living cells is that ultraviolet radiation presents significant phototoxicity. At longer wavelengths, in the visible and near infrared, it is not always possible to find an excitation wavelength to excite a given biological sample-particularly given the lack of tunable visible lasers suitable for microscopy. When the sample does exhibit autofluorescence, it can provide intrinsic contrast, which is important for the development of noninvasive diagnostic techniques. In many cases, however, it is more convenient to label the biological target with a fluorescent molecular species that can be excited using a convenient light source. Fluorophore labels are usually selected for their high fluorescence efficiencies and for their potential to be localized or attached to the biological targets in the sample. The latter issue is nontrivial and has engaged the attention of the biology and chemistry communities for many decades.
Fluorescence lifetime imaging (FLIM) provides a robust functional imaging modality for biomedicine. Recent advances in ultrafast laser and detector technology make FLIM increasingly accessible for life scientists and point the way to new clinical instrumentation. Although the library of fluorescent labels for specific biological targets increases every year, there is usually some compromise made between the impact of the fluorescent label itself on the biological system under investigation and the imaging viability, which includes factors such as the availability of convenient excitation light sources, the overlap of the fluorophore absorption bands with the excitation wavelengths, the fluorescence efficiency and the availability of suitable detectors. The first issue, the perturbation of the target biological system by the fluorescent label, is extremely difficult to fully resolve and is one reason the development of genetically expressed fluorophore labels such as GFP is so exciting. Compared to many fluorescent labels, these fluorophores do not strongly perturb their biological targets and the genetic expression makes it possible to efficiently label specific proteins inside cells; imaging fluorescence intensity distributions can subsequently localize these proteins. The second issue, the imaging viability, is being addressed by developments in instrumentation, particularly lasers. For wide-field fluorescence microscopy, the use of spectrally filtered white light sources provides continuously tunable excitation radiation, although the relatively low spectral density of such sources limits the available power. For laser-scanning confocal microscopy, however, the range of excitation wavelengths has been much more limited; most fluorophore labels have been developed to work with the emission lines of gas lasers and frequency-doubled solid-state lasers. Happily, recent advances in visible diode laser technology and the development of multiphoton excitation with tunable femtosecond Ti:sapphire lasers greatly relax these constraints and the development of new fluorophore labels offers enormous promise. Among these, genetically expressed fluorescent proteins and fluorescence nanosphere technology are particularly exciting. Given the complexity of biological and photochemical systems, however, the timescale to develop new fluorescent labels for specific biological targets is years rather than months. For this reason, there is considerable interest in deploying appropriate source and detector technology to get more information out of existing fluorophore labels.
Quantitative imaging of fluorescence intensity can furnish functional information about a sample since the efficiency of the fluorescence process can reveal information about the fluorophore and its local environment. Fluorescence efficiency is conveniently parameterized by the quantum efficiency , defined as ⌫/(⌫+k), where ⌫ and k are, respectively, the radiative and nonradiative decay rates. The quantum efficiency may also be described as the ratio of the number of fluorescence photons emitted to the number of excitation photons absorbed. The radiative decay rate is related to the transition oscillator strength, while the nonradiative decay rate can vary according to how the fluorophore interacts with its local environment. For some fluorophores, k is sensitive to the local pH, or to calcium ion concentration, or to physical factors such as viscosity. For this reason, fluorescent "probes" may be employed to produce functional maps of perturbations in such environmental factors by recording distributions of changes in k using quantitative fluorescence intensity imaging. In heterogeneous biological samples, however, it can be difficult to measure quantum efficiency because of possible artifacts arising from, for example, nonuniform fluorophore concentration, excitation flux or detection efficiency. Optical scattering can also degrade quantitative intensity measurements. For carefully prepared thin samples, one can assume that some of these factors are uniform across the field of view but for thick samples, and particularly for in vivo imaging, it is often not possible to reliably determine quantum efficiency.
A more robust approach is to make relative intensity measurements at each pixel in the field of view. One approach is to employ special probes with fluorescence spectra that change in a predictable way according to the strength of the local environmental perturbation-the concentration of Ca 2+ ions, for example. By incorporating such probes into a sample and recording fluorescence intensity images at two or more wavelengths, it may be, for example, possible to produce a map of Ca 2+ concentration distributions in order to study signalling in nerve synapses. Such spectrally resolved relative measurements can effectively eliminate factors caused by optical scattering and noise from background fluorescence, as well as nonuniformity in fluorophore concentration, excitation and detection efficiency."Wavelength-ratiometric imaging" has been successfully applied to microscopy and to in vivo diagnostic imaging.
1 Unfortunately, this technique is limited to those instances for which suitable wavelength-ratiometric probes (or endogenous fluorophores) are available, currently a significant restriction.
Fluorescence lifetime imaging (FLIM)
Another way of obtaining functional information from relative intensity measurements (or images) is to temporally resolve fluorescence profiles after pulsed (or modulated) excitation. Just as spectral discrimination adds both a new dimension to fluorescence data and enhanced opportunities for contrast and robust functional imaging, the application of temporal resolution adds yet another dimension. Fluorescence lifetime imaging (FLIM) involves determining the average fluorescence decay time for each pixel in the field of view and producing a map (or series of maps) of lifetime data. It can be seen from Fig. 1 that, like the quantum efficiency, , the fluorescence lifetime () depends on both the radiative and nonradiative decay rates. Like , it can be used to ly available FLIM instrumentation and the significant technological expertise required to develop it in-house has precluded application of FLIM in the life sciences for all but a few specialist groups. Ultrafast laser technology, however, has become increasingly user-friendly-if not increasingly cheap-and the recent proliferation of multiphoton microscopes provides a straightforward route to implementing FLIM with commercially available, off-the-shelf components. Since multiphoton microscopes acquire images by scanning pixel-by-pixel, and they already incorporate an ultrashort-pulsed excitation laser, it is relatively straightforward to add time-correlated single photon counting (TCSPC) to the detection channel and obtain time-resolved fluorescence decay profiles for each pixel. See the book cited in Ref. 8 for a discussion of TCSPC. Multiphoton imaging, which also provides inherent optical sectioning, is particularly effective in highly scattering samples such as living tissue. It is ironic that this "add-on" option to multiphoton scanning microscopes, arguably one of the most technologically complex and expensive instruments for obtaining fluorescence lifetime images, is becoming the most widespread.
An alternative implementation of single-channel FLIM that is applicable to single-photon confocal scanning microscopes can be realized using a frequency-domain approach in which one sinusoidally modulates the excitation laser and applies synchronous detection to determine the phase difference and change in modulation depth between the excitation signal and the resulting sinusoidally modulated fluorescence signal; for example, see the article listed in Ref. 9 . This "lock-in" detection scheme can also be employed using a pulsed source, a solution that has been implemented in multiphoton microscopy. 10 Although in principle, the time and frequency approaches can provide equivalent information, in practice the choice of approach is affected by the specific FLIM application. The frequency-domain approach is sometimes considered simpler and cheaper since it is straightforward to sinusoidally modulate a cw laser for nanosecond measurements. When picosecond resolution is required, however, the necessity of using high-frequency (GHz) electronics means that the cost and complexity of the frequency-domain technology becomes comparable to that of the time domain. A further consideration is that biological systems often exhibit complex fluorescence decays that do not fit a simple mono-exponential decay model. While double exponential decay profiles may be analyzed in the frequency domain, more complex decay profiles, particularly those corresponding to a continuous spectrum of lifetime components, 11 are easier to analyze from direct time-domain measurements.
contrast different fluorophore species (via ⌫) and different local fluorophore environments (via k). FLIM thus provides a robust functional imaging modality that may be applied to any fluorescent sample, and it is currently being applied to biological samples ranging from single cells to bulk tissue. FLIM is also attracting growing interest among researchers active in the field of microanalysis of sample arrays and high-throughput screening. Figure 2 shows examples of wide-field FLIM applied to "functional imaging" of arrays of samples in multiwell plates. 2 Fluorescence lifetime is the contrast parameter that is represented on the false color scale. Figure 2(a) illustrates chemically specific imaging that contrasts two dyes with very different lifetimes (140 ps and 3.5 ns), demonstrating the excellent temporal dynamic range achievable. Figure 2 
FLIM microscopy applied to cell biology
Because FLIM can provide information about the local fluorophore environment, it offers functional information beyond mere localization of a fluorescent label or labelled protein. Figure 3 (a) shows a simple multiwell plate experiment that illustrates how variations in the local solvent refractive index can be reported by the fluorescence lifetime of enhanced green fluorescence protein (EGFP). This new observation 3 may be important to cellular imaging since EGFP is widely used [e.g., for fluorescence resonant energy transfer (FRET) experiments], and its fluorescence lifetime is often assumed to be constant throughout the cell. Figure 3(b) shows a preliminary FLIM image of EGFP-tagged major histocompatibility complex (MHC) protein at a cell surface. We note the unexpected variation in fluorescence lifetime, which may indicate that this protein is expressed in heterogeneous environments at the cell surface.
Although this very recent observation 4 has yet to be confirmed and fully understood, there is clearly great potential in correlating variations in fluorescence lifetime with different cell constituents, e.g., lipids, proteins, etc., and in investigating the dynamics of intercellular and intracellular processes. There are also opportunities to use FLIM with other fluorophore labels (genetically expressed and otherwise) to study biological function and to obtain appropriate biological contrast for assays. FLIM may also be applied to monitoring bimolecular interactions, such as FRET, which reports on the distance between a donor and acceptor molecule, as described, for example, in the proceedings listed in Ref. 5 . This is particularly advantageous if the donor and acceptor emission overlap so that they cannot be spectrally distinguished. 
Technology for FLIM
Most biologically relevant fluorophores exhibit characteristic decay times ranging from picoseconds to nanoseconds. Enhanced green fluorescent protein, for example, typically decays with a mean lifetime of the order of~2.8 ns and many endogenous tissue fluorophores fall within this range as described, for example, in the article listed in Ref. 7 . Imaging with such time-resolution has presented a significant technological barrier to the widespread adoption of FLIM. Until recently, the lack of commercial-FLUORESCENCE LIFETIME IMAGING Apart from cost and complexity, the main drawback associated with using confocal scanning microscopes for FLIM is that this approach can be slow, since all the information is recorded using serial data acquisition. Many biological fluorophores exhibit complex exponential fluorescence decay profiles that require long integration times to achieve a signal-to-noise ratio sufficient for reliable curve fitting. Similar considerations apply to spectrally resolved imaging: it is inevitable that the more functional information is required per pixel, the longer the data acquisition time required for the whole image. Extended confocal image acquisition can lead to photobleaching, although this problem may be ameliorated for many samples by multiphoton excitation. To minimize image acquisition time, reduce photobleaching and facilitate the observation of rapidly evolving systems when undertaking functional imaging, it seems attractive to interrogate all the sample pixels in parallel. Thus, wide-field FLIM, as well as widefield multispectral imaging, offer advantages for biological and medical applications beyond their reduced cost and complexity compared to confocal scanning instrumentation.
Wide-field FLIM
Before the availability of low-cost, high-speed TCSPC cards, FLIM was most commonly realized in wide-field microscopes using either time-domain or frequency-domain detection. Figure 4 shows a schematic of wide-field time-domain FLIM in which time-gated "snapshots" of the fluorescence emission are acquired at various delays after the excitation with ~100 ps shutter speeds, usually achieved using high-speed gated image intensifiers, as described in the article in Ref. 12 . The series of time-gated fluorescence intensity images can then be analyzed to extract the fluorescence decay time for each pixel of the image. Although such timedomain FLIM systems do require ultrafast lasers, which make them expensive and complex, we have demonstrated at Imperial College that they may be implemented using diode-pumped solid-state laser technology 13 or even compact and inexpensive pulsed diode lasers.
14 The data shown in Fig. 2 was obtained using a pulsed diode laser and a gated optical image intensifier (GOI). 15 The same equipment was used to obtain the data shown in Fig. 5 , which shows an autofluorescence intensity map of unstained biological tissue together with a corresponding FLIM map. This example shows how FLIM provides excellent intrinsic contrast between different types of tissue and highlights the potential of FLIM for noninvasive medical imaging. Wide-field frequency domain FLIM is implemented using a sinusoidally modulated excitation beam. Wide-field synchronous detection may be realized using an optical image intensifier with sinusoidally modulated gain, as described in Ref. 16 .
High-speed multidimensional functional fluorescence imaging
The parallel pixel acquisition of wide-field FLIM facilitates highspeed imaging. Since recent advances in CCD technology permit image-acquisition rates exceeding 1000/s, it becomes possible to contemplate the use of functional fluorescence imaging to study the dynamics of evolving systems, such as nerve synapses, on unprecedented timescales. Wide-field FLIM inherently acquires 3D data sets corresponding to time and two spatial dimensions. Further functional information may be obtained by use of appropriate wide-field techniques for multispectral imaging, polarizationresolved imaging and optical sectioning.
Multispectral FLIM
Wide-field multispectral imaging may be readily implemented using dichroic beam splitter(s) to divide the incoming fluorescence images into a number of sub-images that are spatially identical but which correspond to different spectral pass-bands. This functional imaging modality, powerful on its own, may be combined with FLIM, by use of time-gated image intensifier technology, to provide 4D fluorescence imaging that resolves two spatial dimensions, time and wavelength.
17 Figure 6 (a) is a schematic of the wide-field multispectral imaging device, 18 which we place in front of the gated image intensifier. This approach to multispectral FLIM, which can increase the ability to contrast different fluorophores or fluorophore environments without compromising imaging speed, could one day be important for medical diagnostic imaging.
Fluorescence lifetime and anisotropy imaging
FLIM may be combined with a polarization-resolved imaging module, as illustrated in Fig. 6(b) , to realize time-resolved fluorescence anisotropy imaging (TR-FAIM). If a fluorescent sample is excited by a polarized light field, the resulting fluorescence will initially be predominantly polarized parallel to the excitation light, i.e., the fluorescence radiation will be emitted anisotropically. But subsequent tumbling, or in other words rotational diffusion of the fluorophores, will result in a randomization of their orientation. Thus, over time, there will be no net polarization of the fluorescence light. By determining the timescale over which the degree of polarization decays away-and hence the timescale over which the orientation of the fluorophores becomes randomized-it is possible to learn more about the fluorophores and their local environment. For instance, this rotational "correlation time" is a function of the solvent viscosity and the size and shape of the fluorophores. It is also affected by other events that hinder rotation, such as binding. Images of the rotational correlation time can therefore provide information about cellular dynamics and ligand binding, among other processes. This information can be applied in functional microscopy or in assays. We have recently extended our wide-field time-gated FLIM technology to time-resolved fluorescence anisotropy imaging by use of a polarization-difference imager in front of the time-gated detector. 19 This device splits the fluorescence image into two spatially identical components with polarizations that are resolved parallel and perpendicular to the polarization direction of the excitation light. By recording polarization-resolved, time-gated images at each time step, it is possible to calculate maps of both the fluorescence lifetime and the rotational correlation time of a sample, or an array of samples, in the field of view. Fluorescence lifetime and anisotropy imaging (FLAIM) allows us, for example, to simultaneously image distributions of variations in both refractive index and viscosity. Figure 7 shows the calculated fluorescence lifetime and rotational correlation time maps for samples of Rhodamine 6G dissolved in four solvents of varying viscosity. We attribute the difference in fluorescence lifetimes to different solvent refractive indices. We are currently working on applying this technique to live cells.
Wide-field FLIM with optical sectioning
FLIM implemented with confocal scanning technology (and multiphoton microscopy) provides inherent optical sectioning, which is highly desirable. There have been a number of approaches to the realization of wide-field optical sectioning. One of the most established is multifoci confocal microscopy, 20 sometimes described as tandem scanning confocal microscopy. This approach uses an array of "pinholes" to interrogate many pixels in parallel. A recent advance is multifoci multiphoton microscopy, in which an array of near infrared excitation beams is scanned across the focal plane to create a pseudo-wide-field sectioned fluorescence image. 21 True wide-field optical sectioning has been demonstrated using the technique of structured illumination, which computes a wide-field sectioned image and a conventional wide-field image from three acquisitions of spatially modulated images. 22 All these techniques can provide 3D intensity images and may be combined with multispectral imaging and with FLIM to realize high-speed wide-field functional imaging. We have combined FLIM with wide-field sectioning using structured illumination. 23 We demonstrated 5D fluorescence imaging for the first time by also implementing multispectral imaging. 17 Figure 8 shows an example from a 5D data set in which a sample containing two types of fluorescent microspheres are resolved temporally, spectrally and in three spatial dimensions. We believe that this multidimensional, high-speed approach to functional bioimaging provides a powerful tool for fundamental research, assay FLUORESCENCE LIFETIME IMAGING technology and clinical diagnosis. Figure 9 shows a preliminary result in which structured illumination has been used to acquire wide-field, optically sectioned fluorescence intensity and FLIM maps of B cells expressing EGFP-tagged class I MHC protein in the membrane. 24 
Endoscopic FLIM
FLIM may be applied to almost any wide-field imaging system, including endoscopes. We have investigated FLIM with rigid arthroscopes and with flexible fiber-bundle-based endoscopes. Figure 10 shows two FLIM images acquired through a flexible endoscope incorporating a 2-m long bundle of multimode step-index optical fibers. 25 As the figure shows, a clear contrast is observed between the multiwell plate samples of DASPI and EGFP. Intrinsic FLIM contrast from autofluorescence of biological tissue is also observed.
We have not experienced significant problems with temporal dispersion in the fiber bundles and we believe that FLIM endoscopy can be an important clinical diagnostic tool. Significant issues to overcome, however, include the development of low-cost and compact tunable ultrafast sources, efficient coupling and transmission through the endoscope and appropriate techniques to handle the complex fluorescence decay profiles presented by most biological tissues. Nevertheless, our early results indicate that FLIM can potentially contrast different states of tissue components, such as collagen and elastin. The technique could be used both to find evidence of disease and as a real-time monitor of tissue during minimally invasive surgery.
Outlook
FLIM is a widely applicable fluorescence imaging modality that can provide contrast between different types or states of biological tissue. Although it is not a new technique, the recently available combinations of tunable ultrafast laser sources and relatively low-cost detectors, together with its rapid uptake as an add-on to multiphoton microscopes and its ability to enhance FRET measurements, have produced a significant increase in the interest FLIM attracts. Ultimately we believe that FLIM will have a much wider impact in lower cost, robust implementations for diagnostic medical imaging, for high-throughput screening and other assay technologies and for wide-field functional imaging for molecular and cell biology, including high-speed applications.
Key technological components required for widespread adoption are ultrafast laser sources and high-speed imaging detectors. While the former are also required for multiphoton microscopy, this has not yet been sufficient to drive down the price of ultrafast solid-state lasers. Because FLIM does not need the high intensities required for multiphoton microscopy, it is able to take advantage of sources providing longer pulses (up to a few 100 ps) and lower power. Thus cheaper, more compact technologies such as gainswitched diode lasers and microchip lasers can play a role, particularly in wide-field instruments. Frequency-domain FLIM can also be implemented with diode lasers and LEDs. High-speed detectors and TCSPC technology have become significantly cheaper in the past few years, a trend that will enhance confocal and multiphoton FLIM microscopy as it has the field of time-gated optical tomography. Today, wide-field time-gated and phase-modulated detectors based on image intensifiers cost what a scientific CCD camera did ten years ago. With a relatively modest increase in sales volume, the technology can be significantly cheaper, particularly if optimized for a specific application and lifetime range. In the near future, there are likely to be low-cost FLIM systems based on directly gated CCD or CMOS imaging sensors.
The challenge is to work with research-orientated FLIM instrumentation and identify applications for which optimized, lower cost technology will be developed. At Imperial College, we are focusing on autofluorescence contrast in biological tissue for diagnosis and monitoring of disease, as well as on multidimensional functional fluorescence-based imaging for cell and molecular biology, with emphasis on the immune synapse. We have an increasing interest in developing assay technologies. Some major challenges are to understand how to interpret FLIM data, to catalogue fluorescence lifetime contrast "signatures" over extended spectral and temporal ranges and to explain the biological and physiological origin of the observed FLIM contrast. In general, although the rapidly growing FLIM community faces many challenges, we believe the technology offers enormous opportunities. 
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